Clinical Trial Update: REACT-01: Reversing Autoimmunity Through Cell Therapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial, REACT-01, is evaluating a cell therapy approach to reversing autoimmunity in systemic lupus erythematosus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• REACT-01 Cell Therapy

Snippet

Sponsor: Seattle Children's Hospital | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING